PharmaReports: Cancer Immunotherapy
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel is dedicated to immunotherapy approaches to cancer such as interleukins and other immunostimulators. Oncolytic viruses and cell based therapies are also included in this channel. Most reports included in this channel are technological in approach.
Showing results 151 - 170 of 170
- Vaccine antigen delivery technologies - Molecular systems to open new markets
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- World Market for Cancer Therapeutics and Biotherapeutics
- Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
- Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
- Accelerating Lead Generation: Emerging technologies and strategies
- Monoclonal Antibodies in Cancer Therapy 2009-2024
- Monoclonal Antibody Therapeutics 2009-2024
- Innovations in Oncology Diagnostics: Technological advances, growth opportunities and future market outlook
- Launching Next Generation Oncology Products: Evolving Strategies in a Payor’s Market
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
- Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
- Pipeline Insight: Biologic Targeted Cancer Therapies - Next generation jostles for market position
- Cancer Therapeutics: Market Insight and R&D Pipeline Analysis
- Therapeutic Vaccines - A far-off promise of greatness
- Non-Hodgkin's Lymphomas Diffuse large B-cell lymphoma and follicular lymphoma
- Molecular Diagnostics in Cancer Testing
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development